Let’s make your biologic easier to deliver.
AEMS explores established excipient combinations to reduce viscosity and support high-concentration formulations for subcutaneous delivery.
Let’s follow up.
A better way to explore
what’s already in your lab.
PROPEL combines experimental design, robotic automation and machine learning. Each experiment helps guide what we test next.
Let’s discuss your molecule and whether a focused feasibility study could help.
Read Scott and Alex’s article in ONdrugDeliveryYOUR CONVERSATION STARTS WITH US
